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ABSTRACT. Bone cell interaction with extracellular matrix (ECM) microenvironment is of 
critical importance when engineering surface interfaces for bone regeneration. In this work layer-
by-layer films of type I collagen (coll), the major constituent of bone ECM, and heparin (hep), a 
glycosaminoglycan, were assembled on poly(L-lactide acid) (PLLA) substrates to evaluate the 
impact of the biomacromolecular coating on cell activity. The surface modification of PLLA 
demonstrated that the hep/coll multi-layer is stable after 10 bilayers (confirmed by contact angle, 
infrared spectroscopy and morphological analysis). This simple approach provided novel 
information on the effect of heparin on type I collagen hierarchical organisation and subsequent 
cell response of osteoblast-like (MC3T3-E1) and human bone marrow-derived mesenchymal 
stem cells (hMSCs). Interestingly, the number of deposited heparin layers (1 or 10) appeared to 
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play an important role in the self-assembly of collagen into fibrils, stabilising the fibrous 
collagen layer, and potentially impacting on hMSCs activity.  
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INTRODUCTION 
The use of materials that are both biodegradable and biocompatible for the manufacture of 
biomedical implants for bone regeneration has increased. Poly (lactic acid)  is one of the most 
used polymers in the field of orthopedics due to its biocompatibility, biodegradability, 
thermoplastic processability and mechanical properties1. This material has been used for 
developing sutures, screws and fixation plates in bone fractures, constructs for bone and cartilage 
repair, drug release systems, and devices for ligament/tendon healing 2. With advances in tissue 
engineering, there is the opportunity to promote bone regeneration rather than provide a mere 
structural support. An optimal bone graft material should induce osteogenesis and therefore 
promote appropriate osseointegration. By incorporating specific structural components such as 
collagen, and GAGs to mimick the native extracellular matrix (ECM) microenviroment at the 
surface of the implant it is possible to modulate specific cellular interactions and influence 
localized tissue response.  
Type I collagen has previously been demonstrated to accelerate osteoblast differentiation and 
matrix mineralisation in vitro 3; however a critical level of collagen (~2.4 mg/ml) is required to 
achieve this effect 4. Glycosaminoglycan (GAG) chains on ECM proteoglycans are able to bind 
different growth factors and maintain the required ECM-space for bone development 5. Heparin 
is a highly sulphated GAG capable of storing and releasing growth factors 6. Several proteins 
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contain heparin-binding domains, resulting in a strong interaction between this polysaccharide 
and the ECM components involved in cell adhesion 7, proliferation and osteogenic differentiation 
8. Combining collagen and heparin is therefore a system based on natural compounds with 
unique biological properties, that are Food and Drug Administration (FDA) approved, and can be 
easily applied to clinical applications. Previous studies on the interaction of collagen and heparin 
have demonstrated that heparin has a direct impact on the kinetics and morphology of 
reconstituted collagen type I fibrils 9-10. Collagen and heparin has been reported as a coating of 
tricalciumphosphate/hydroxyapatite (TCP/HA) granules for long term delivery of BMP-2. A 
local and sustained delivery system for BMP-2 after 21 days was obtained, suggesting this 
collagen/heparin system as a potential BMP-2 carrier to enhance bone regeneration in large bone 
defects 11. The response of mesenchymal stem cells (MSC’s) to the combination of collagen and 
heparin, has been previously studied on aligned collagen type I matrices using a microfluidic set-
up to then incorporate the heparin. The study has reported that the extent of osteogenic 
differentiation was not significantly affected by aligned and heparin-functionalised substrates 12.  
In this context the lack of effect of collagen and heparin on osteogenesis and MSC’s 
differentiation could be related to the very specific collagen/heparin organisation, topography, 
and chemical composition.  
To overcome these limitations, the layer-by-layer (LbL) assembly method possesses  advantages 
for recreating native ECM microenviroments for bone tissue regeneration by allowing the self-
assembly of highly organized 3D complex structures in vitro 13-14. Due to its versatility and 
simplicity for incorporating high levels of different types of biomolecules with a fine control 
over multilayer structures, by alternating adsorption of oppositely charged polyelectrolytes, LbL 
assembly provides a rational method towards the control of cell behaviour at the implant 
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interface. Previous studies using LbL assembly of collagen and heparin have been performed on 
titanium 15-18, porous hydroxyapatite19, ePTFE20  to study blood compatibility, vascularisation 
and angiogenesis. Although, the collagen and heparin system has been studied mostly as a carrier 
for drug delivery or system to promote vascularisation, the polyelectrolyte multilayers of 
collagen and heparin on a PLLA biodegradable polymer and its effect on bone cells and human 
mesenchymal stem cells has not previously been investigated.  
In this work, we optimised and confirmed successful LbL heparin/collagen assembly on PLLA 
using water contact angle, attenuated total reflectance Fourier transform infrared spectroscopy 
(ATR-FTIR) and X-ray Photon Spectroscopy (XPS) to evaluate the effect of the heparin and 
collagen functionalisation (varying the numbers of the final layers) on the physical-chemical 
characteristics. Furthermore, the selected collagen/heparin multilayers were further investigated 
in vitro by culturing osteoblast-like (MC3T3-E1) and human bone marrow-derived mesenchymal 
stem cells (hMSCs) at short and mid-term, respectively. Results reported in this work are 
relevant for understanding the effect of heparin (GAGs) on collagen properties as main structural 
protein in our body and their impact on MSC activity and osteogenesis when engineering 
construct interfaces to enhance biocompatibility, modulate specific cell behaviour, facilitating 
differentiation and matrix mineralisation. 
 
MATERIALS AND METHODS 
Materials: Type I collagen was isolated and purified form rabbit bone after pepsin digestion as 
described by Ferreira et al. 21. Sodium heparin was purchased from Polysciences Inc. (Italy, Mn: 
100M USP Units). PLLA 3051D was purchased from PuracBiochem (Italy, Mn of 100,000 Da). 
Bi-distilled water was used in all experiments. Conventional circular borosilicate glasses 
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coverslips for microscopy with 13 mm diameter (VWR, UK) were used for the preparation of the 
nano-coated PLLA films via LbL assembly. Cleaned borosilicate slides were used as control. 
Dulbecco’s modified Eagle’s medium (DMEM) from Sigma-Aldrich (UK) was used containing 
1000 mg glucose/L pyridoxine HCl and NaHCO3 and, supplemented with 10% of heat 
inactivated fetal bovine serum (FBS; from LonzaTM, UK), 2mM L-glutamine and 100 units/ml 
penicillin/ 100 µg/ml streptomycin (Gibco, Life technologies Ltd. All media was kept 
refrigerated at 4°C and pre-warmed at 37°C before use. 
Preparation of PLLA films by spin coating. The borosilicate glasses were cleaned using 
“Piranha cleaning solution” (mixing 1:1 v/v ratio of sulphuric acid and hydrogen peroxide - 
H2SO4 and H2O2, Sigma-Aldrich, Italy) in order to remove any impurities or particles adhered to 
the surface that could interfere with the further chemical functionalisation. After one hour, 
glasses were rinsed three times with distilled water plus once with 70% ethanol solution (Sigma-
Aldrich, Italy), dried with nitrogen gas and stored under vacuum. Silanisation treatment was 
performed on cleaned glasses to promote the chemical interaction between polymer and glass 
substrates and prevent the peeling-off of the polymeric film along the experiment. In details, 
cleaned glass substrates were immersed into 2% solution of 3-aminopropyltriethoxysilane in 
diethylene dioxide (1,4-dioxane; Sigma-Aldrich, Italy) for 3 hours at room temperature, 
protected from light and water. Silanised glasses were rinsed three times with 1,4-dioxane, 
followed by 20 min of ultra-sonication in fresh 1,4-dioxane and dried with nitrogen gas. A 
puddle of 35 μl PLLA 5% (v/w) solution in 1,4-dioxane was deposited onto the centre of the 
glass substrate, and spun at 1000 rpm for 3 s followed by 10 s at 7000 rpm using a spin-coater 
instrument (Bench Top Spin Coater, MTI tech, LTD, UK). Glasses were spin-coated twice with 
PLLA solution to increase the polymer film thickness and heated at 70°C (over the PLLA glass 
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transition, approx. 65°C) for 45 min in order to facilitate the reaction between the amino groups 
present on silanised glass and the ester-groups of PLLA polymer, to ensure the evaporation of 
remaining solvent and to anneal any orientation or mechanical stresses induced by the spin 
coating process. 
Heparin and collagen Layer-by-Layer assembly. PLLA films were aminolysed by treating 
them during 14 min into 0.06 g/ml solution of 1,6-hexanediamine/2-propanol (Sigma-Aldrich, 
Italy) at room temperature (25°C). Aminolysed films were washed with a large quantity of water 
and dried under reduced pressure at 30°C 22-23. The amount of amino groups present on 
aminolysed PLLA surfaces was determined by the Acid Orange II (AOII, Sigma-Aldrich, Italy), 
also known as Acid Orange 7. This colorimetric method is based on the principle that positively 
charged amino groups on material surfaces can combine by an ion exchange mechanism with 
negatively charged dye under acidic conditions 24. Briefly, films of 1 cm2 were immersed in 1 ml 
of an aqueous solution of 500 μmol/l Acid Orange II at pH 3 (diluted HCl) and incubated under 
agitation at room temperature for 24 h to carry out the protonation of the amines. Films were 
washed with acid water at pH 3 (diluted HCl). The bound dye was released in 1 ml of distilled 
water at pH 12 (diluted NaOH) after 15 min of shaking at room temperature and measured 
spectrometrically at a wavelength of 492 nm (UV-Vis Spectra PerkinElmer, Lambda 25). From a 
standard curve, the concentration of amino groups was determined using the assumption that one 
amino group (–NH2) is complexed by one equivalent of Acid Orange II. All measurements were 
performed in triplicate. 
Positively charged PLLA surfaces were coated with multiple alternating layers of collagen and 
heparin as shown in figure 1. The LbL deposition was performed by depositing 50 µl of 
biopolymer solution onto the aminolysed PLLA surface for 10 min, starting with the heparin 
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(hep) as first layer, followed by a washing step with distilled water for 10 min to remove 
unbound molecules of heparin. Collagen (coll) solution (50 µl) was deposited during 10 min, 
followed by washing with distilled water; repeating the entire cycle up to ten times. Biopolymer 
solutions - heparin and collagen - were prepared with concentration of 1 mg/ml and pH adjusted 
to 5. Distilled water was used to prepare all solutions, including the washing baths. 
The final multilayers were coded with the initial letter of the last polyelectrolytes coated (C for 
collagen and H for heparin), followed by the number of bilayer created. 
Figure 1. Illustration of Layer-by-Layer process with collagen and heparin onto poly-lactic acid 
polymeric substrates. 
Physico-chemical analysis of multi-layered samples. Surface morphology of hep/coll coatings 
and controls were evaluated by Scanning Electron Microscopy technique (SEM LEO1430VP). 
SEM micrographs were taken at varying magnification, using working distance (WD) of 10mm 
and an electron high tension of 20kV (EHT). Prior to the SEM analysis, samples were coated 
with a conductive thin gold layer. 
Surface hydrophilicity of controls and heparin/collagen layers was evaluated by Static Water 
Contact Angle. The measurements were performed at room temperature using a Contact Angle 
CAM 200 KSV Instrument, equipped with Tetha software using the sessile drop method, 
dispensing 3 μl water droplet (HPLC grade) directly on the sample surface by a motor driven 
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syringe. Contact angle measurements were analysed using automatic software and presented as 
the average of three measurements from three different points on each surface. 
Chemical properties of deposited heparin and collagen layers were evaluated by mid-infrared 
spectroscopy. FTIR spectra of 36 scans at 4 cm-1 resolutions were obtained by a Frontier 
PerkinElmer FT-IR spectrophotometer with a universal attenuated total reflectance (ATR) 
module in Germanium crystal. 
Surface composition was determined by X-Ray Photoelectron Spectroscopy (XPS; Theta 
Probe, Thermo Scientific, East Grinstead, UK), which uses a micro- focused AlKa X-ray source 
(1486.6 eV), operated with a 400 µm spot size (100 W power). Survey spectra were collected at 
a pass energy of 200 eV, a step size of 1 eV and a dwell time of 50 ms, with the spectrometer 
operated in standard (not angle-resolved) lens mode. High resolution regional spectra were 
collected using a pass energy of 40 eV, a step size of 0.1 eV and a dwell time of 200 ms. High 
resolution spectra envelopes were obtained by curve fitting synthetic peak components using the 
software CasaXPS. 
Quantification of the biomolecules assembled within the films. Taylor`s Blue colorimetric 
method was used to quantify heparin content. Taylor’s Blue solution was prepared by dissolving 
3.04 g glycine (Sigma-Aldrich, Italy), 2.37 g NaCl (Sigma-Aldrich, Italy) and 16 mg of 1,9-
dimethylmethylene blue dye (Sigma-Aldrich, Italy) in 95 mL of 0.1 M HCl and completed with 
deionized water to make the solution up to 1 liter. Films were cut into square samples with a 
surface of 1 cm2 and incubated in 1 ml of Taylor’s Blue dye reagent in capped tubes for 30 min. 
Samples were washed with deionised water and transferred to new tubes. Then, 1 ml of 
dissociating agent (3M Guanidine hydrochloride - GuHCl (Sigma-Aldrich, Italy)) in Phosphate 
Buffer Saline (PBS, Sigma-Aldrich, Italy) at pH 7.5) was added to each sample and shaken in a 
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vortex mixer for 10 min to facilitate the release of the bound dye 1,9-dimethylmethylene blue 
dye molecules into solution, turning the coloration of dissociating reagent from crystalline to 
blue. Each sample solution was transferred to disposables cuvettes and the absorbance was 
measured at 653 nm using an optical spectrophotometer (Perkin Elmer Instrument Lambda 40). 
Measured absorbance was assessed against dissociation reagent alone for the blank, calibration 
curve standards and test samples. Heparin density was calculated through a calibration curve 
previously built at different known heparin concentrations (0-5 µg/mL). All the measurements 
were performed in triplicate. 
The amount of collagen present in the multi-layered PLLA films was quantitatively 
determined using Sirius red-based colorimetric method. Films were cut into square samples with 
a surface of 1 cm2 and incubated into 1 ml of Sirius red dye reagent into a cap tube for 30 min in 
order to form a collagen-dye complex. Sirius red solution was prepared by dissolving 0.5 g of 
Direct Red 80 (Sigma Aldrich, Italy) into 500 ml of saturated aqueous solution of picric acid 
(1.3% in water). Thereafter, the dye solution was drained and the stained samples were washed 
twice with iced-cold acidified water (containing 0.5% acetic acid and sodium chloride) in order 
to remove the unbound dye. The washing solution was removed as well as any fluid from the lip 
of the eppendorf tubes using cotton wool buds. The bound dye was dissolved by adding 1 ml of 
the alkali reagent (0.5 M sodium hydroxide) to the samples and mixed for 10 min. The collagen 
bound-dye was transferred into disposables cuvettes and optical density was measured at 560 nm 
with UV-Vis scanning spectrophotometer (PerkinElmer, Lambda 40). The density of collagen 
bound to PLLA films was calculated using a calibration curve prepared with known collagen 
concentrations. All the measurements were performed in triplicate. 
 10 
Short term in vitro evaluation of multi-layered films with collagen and heparin using MC3T3 
cells. Short-term in vitro study (up to 3 days) was performed using the pre-osteoblastic cell line, 
MC3T3-E1 to evaluate the influence of hep/coll layer-by-layer films on cell morphology and 
viability. Prior to seeding the cells on surfaces, samples were sterilised with UV light (Polaris 
UltravioletTM germicide lamp) at 208 nm for 30 min. 
MC3T3-E1 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Gibco, Grand 
Island, NY, USA) containing 10% (v/v) fetal bovine serum (FBS; Gibco), 2 mML-glutamine (L-
G), 100 units/ml penicillin and 100 µg/ml streptomycin (P/S). One millilitre of MC3T3-E1 cells 
suspension containing 10,000 cells was dispensed onto each samples films (Ø= 13mm). Cells 
were incubated on the multi-layered substrates placed in 24-well tissue culture plates (Lonza, 
UK) at 37 °C in an atmosphere containing 5% CO2 for up to 7 days. All experiments were 
repeated three times. 
Cell morphology was characterised by fluorescent microscopy. For this purpose, culture media 
was removed from each well and samples were washed twice with Dulbecco's Phosphate 
Buffered Saline (DPBS), Lonza (UK). Cells adhered to the sample surface were fixed in 4% 
(w/v) paraformaldehyde (Sigma Aldrich, UK) in PBS preheated at 37 °C for 20 min. 
Subsequently, fixative solution was drained and samples were washed three times with 
DPBS/0.1% (v/v) Tween 20. Samples were blocked in 3% (v/v) goat serum (Sigma Aldrich, UK) 
in DPBS/0.1% Tween 20 for 30 min and then incubated with 200µL of Rhodamine phalloidin 
(Sigma Aldrich, UK) in DPBS/0.1% Tween 20 [1:1000] for 20 mins. Samples were then washed 
three times with DPBS/0.1% (v/v) Tween 20 and mounted onto microscope glass slides (VWR, 
UK). Cell nuclei were visualised with DAPI (Sigma Aldrich, UK) included in the anti-fade 
mounting medium (Vector Labs Inc). Samples were imaged on a fluorescent microscope DMLB-
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Leica Fluorescent light Microscope combined with Camera-Advanced SPOT. The cell and 
nucleus shape analyses were performed manually by defining the regions of interest using Image 
J software. 
Cell viability was evaluated by using the MTT assay (Sigma Aldrich, UK). For this purpose, 
the culture media was removed and 200 μl of 1 mg/ml MTT in DMEM (phenol red and serum 
free) was added to each well. Samples treated with MTT reagent were incubated for 4 hours at 
37°C. Then, media was carefully removed and 100 μl of isopropanol was added to each well to 
solubilise the tretrazolium crystals. The multi-well plate was covered with tinfoil and agitated on 
an orbital shaker for 30 min. Solubilised formazan (100 μl) was transferred to a 96-multiwell 
plate and the light absorbance read at λ=560nm using a Sunrise Elisa plate reader (XFLUOR4 
V4.51). 
In vitro study of coll/heparin multi-layered films using human bone marrow-derived 
mesenchymal stem cells (hMSCs). In vitro cellular studies of layer-by-layer films of heparin and 
collagen were evaluated in short-term (up to 7 days) and long-term (up to 28 days) experiments 
using hMSCs isolated from a 21 years old female (Lonza Inc.,USA). hMSCs were seeded in 
basal media (DMEM-low glucose without glutamine, 10% heat-inactivated fetal bovine serum, 2 
mM L-Glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin) and incubated in 5% 
CO2 humidified atmosphere at 37°C. Basic fibroblastic-growth factor (b-FGF) at a concentration 
of 10 ng/ml was added in order to stimulate cell proliferation. Cells at passage 5 were used in 
this experiment. Samples (in quadruplicates) were placed in a 24-well tissue culture plate 
(Lonza, UK) and one millilitre (1ml) of hMSCs suspension containing 20,000 cells was added to 
each sample: PLLA substrates, 1 layer of heparin (H1), 1 layer of collagen (C1) and 10-layers of 
collagen (C10). 
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Metabolic activity on hep/coll multilayers was measured by MTT based assay at 1, 3, 7, 14 and 
28 days, as described previously. The activity of alkaline phosphatase (ALP) was assessed using 
the p-nitrophenol assay after 7, 14, and 28 days of culture. Nitrophenyl phosphate (pNPP; 
Sigma-Aldrich, UK), which is virtually coluorless shifts to a yellow end-product, p-nitrophenol, 
when hydrolyzed by alkaline phosphatase. The culture media was removed from cell cultures 
and samples were rinsed three times with DPBS. Samples were fixed by adding 300µL of 4% of 
parafolmadehyde fixative solution preheated at 37°C to each well and left for 10 min. Fixative 
solution was drained and samples were washed twice with DPBS, followed by one last wash 
with 0.1M Tris, pH 8.3 to alkalinise the samples. Fixed cells were incubated with 500ul of pNPP 
liquid substrate system at 37°C for 30 min, until yellow colour developed. Subsequently, 100µl 
of each sample was transferred in triplicate into a 96-well plate and ALP values were read at 405 
nm in a Sunrise plate reader (Tecan). A standard curve for absorbance was prepared by serial 
dilutions of 50µmol/L p-NP p-nitrophenol solution in 0.1M Tris (pH 8.3), transferring 100ul of 
standards and blanks to a 96-well plate. ALP concentrations were read off from the standard 
curve. ALP was normalised with the total number of cells adhered to the samples surface 
determined through the Crystal violet assay, and time of ALP incubation (30 min). Cells were 
fixed by adding 300µL of 4% (w/v) of paraformadehyde and incubated with 200ul of 0.1% (w/v) 
pre-filtered Crystal Violet solution for 10 min at room temperature. The stained cells were then 
washed with water three times, air dried and crystal violet solubilised with 100ul of 95% of 
ethanol for 15 min at room temperature. Solubilised crystal violet was mixed and transferred to a 
96 multi-well and light absorbance measured at λ= 570nm using a Sunrise Elisa plate reader 
(XFLUOR4 V4.51).  
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Histochemical staining was performed to assess attached cells population expressing ALP 
enzyme and identify mineral deposits. Briefly, Naphthol solution was prepared by adding 5 mg 
of Naphthol AS MX-PO4 (Sigma) to 200μl of DMF (N,N-Dimethylformamine, Fisher 
Scientific) and 30 mg of Fast Blue RR (Sigma) to 25 ml Tris-HCl (MW. 157.6), 0.2M, pH 8.3. 
Both solutions were mixed and filtered, and distilled water was added to complete the substrate 
solution. After the washing time, water was removed and samples were incubated with 500ul of 
Naphthol substrate during 45min at room temperature. Samples were rinsed three times with 
ultrapure water and stored in water for 5 min. Mineral deposits was determined by Alizarin Red 
staining. Wash water was carefully aspirated from wells and samples were incubated with 300 μl 
of 2% (w/v) Alizarin Red solution, pH 4.2 at room temperature for 30 min. Alizarin Red 
Solution was then removed and samples were washed several times with distilled water. ALP 
positive areas appear purple, while calcium deposits were stained orange/red by the Alizarin Red 
solution and visualised by bright field microscopy (DMLB-Leica Fluorescent light Microscope 
combined with Camera-Advanced SPOT). 
Statistical analysis. The statistical analysis in terms of significant difference of collagen 
biomolecules quantification and cell adhesion and ALP expression was performed for n= 3 
samples by ANOVA (one-way analysis of variance) using Origin-7 software. The post-hoc 
multiple comparisons between the independent groups were evaluated using the Tukey’s test. 
 
RESULTS AND DISCUSSION 
To allow LBL assembly on the polymer, PLLA films were activated through an aminolysis 
process in order to positively charge the surface, and favour the absorption and electrostatic 
interaction with first polyelectrolyte layer. Primary amines introduced by aminolysis treatment 
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onto PLLA substrates were quantitatively assessed by the acid orange II assay. The density of 
NH2 groups on the substrates was determined to be 1.6 ± 0.5 µg/cm2. Surface hydrophilicity was 
slightly increased after the aminolysis treatment of the surfaces, with lower water contact angles 
(about 75 ± 3°) compared to untreated PLLA surface values of 79 ± 3° (Figure 2A). 
Heparin and type I collagen were used as bioactive polyions for LbL assembly in order to 
create a surface that mimics the characteristics of the ECM, as reported also in literature for other 
applications 20. The wettability of surfaces coated with hep/coll multilayers was evaluated by 
water contact angle (Figure 2A). Water contact angles were measured for controls (PLLA and 
aminolysed surfaces) and for 1, 5, 10 and 20 hep/coll multilayers. No-major changes in terms of 
surface wettability were observed after the deposition of one bi-layer of hep/coll in comparison 
with the control (contact angle values close to 80°). However, the deposition of five bilayers of 
hep/coll enhanced significantly the hydrophilicity of the polymeric surface, resulting in contact 
angle values in the range of 60° to 70°. Contact angle values were similar (about 62°) on surfaces 
coated with 10 and 15-bilayers of hep/coll. However, the surface hydrophilicity was significantly 
reduced when the number of deposited hep/coll films was increased up to 20-layers of collagen. 
This result suggests that the surface has become saturated, decreasing the electrostatic stability 
between the multilayers and preventing deposition of additional coating. 
The chemical surface properties of 1, 5, 10, 15 and 20 multilayers of heparin and collagen 
were evaluated by FTIR-ATR technique (Figure 2B)  
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Figure 2. A. Water contact angles of PLLA substrates surface after hep/coll layers depositions 
by LbL technique. B. FTIR-ATR spectra of control and layered surfaces with 1 (green), 5 (grey), 
10 (blue), 15 (red) and 20 (black) films of hep/coll. Solid line corresponds to heparin and dash-
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line to collagen spectra, as the outermost layer. C. SEM micrographs of 10, 15 and 20 hep/coll 
films morphology. Scale bars correspond to 2 µm. 
FTIR-ATR spectra of 1-layer of heparin (H1) layer showed two new peaks at 1674 and 1552 
cm-1 (not detected on the control group) demonstrating the amide bond formation between the 
amino groups superficially exposed on the aminolysed surface and the carboxyl groups of 
heparin. Moreover the collagen α-helix presents three typical absorptions: (1) N-H stretching in 
the vibration frequency range 3290-3300 cm-1, (2) C=O stretching (amide I) between 1648-1660 
cm-1 and (3) N-H deformation (amide II) at 1540-1580 cm-1. Because the amide bond position is 
dependent on the secondary structure of the species, as the number of hep/coll films increased, 
the asymmetric stretching of the carbonyl group (amide I at 1674 cm-1) was slightly shifted to 
1658 cm-1 by the presence of the strong absorption of collagen amide I at 1633 cm-1 25. This 
effect was particularly evident after the deposition of 5 bilayers of hep/coll. The intensity of N-H 
bending of amino groups (amide II) vibration at 1552 cm-1 increased when 5-layers of collagen 
were deposited (C5). Moreover, the peak of the symmetric –NH3+ deformations - also present in 
this region – increased its intensity correlating with elevated collagen charge density. Two new 
peaks at 3322 cm-1 and 3089 cm-1 associated with the N-H stretching were detected on surfaces 
coated with 5 collagen layers up to 20 multilayers of heparin and collagen. The presence of 20-
bilayers of hep/coll showed a decrease of the peaks associated with amide I and II as well as N-H 
stretching, when compared to the surface coated with 15-bilayers (C15). A new peak at 997 cm-1 
attributed to the C−O−S stretching vibration was found in the spectrum of the 20-layer of heparin 
(H20) sample. Therefore, the deposition of multiple hep/coll films (more than 15 bilayers) 
resulted in the decrease of the characteristic peaks associated with collagen such as amide I and 
II. It may be possible that the presence of heparin, which is a strong polyanion, might orient and 
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bind the positively charged collagen deposited layers until the net charge of collagen turns 
negative, restricting the hep/coll assembly process 26-27. Since the electrostatic interactions 
dominate the species absorption, electrostatic repulsion is considered the main contribution 
between the negative charged heparin and the outermost polyelectrolyte layer. The saturation of 
the superficial charge density of the hep/coll film may result in the superficial charge reversion 
and consequently, in the repulsion between the charges of both polyelectrolytes groups. This 
effect decreases the protein absorption and constrains the LbL assembly process 28. Therefore the 
LbL process of heparin and collagen started to be reversed with the assembly of more than 15 
layers of hep/coll. Thus, multilayers of heparin and collagen were chemically stable up to 10-
bilayers of hep/coll. Moreover, water contact angle results have demonstrated continued 
hydrophilic properties in surfaces coated with 10 bilayers of hep/coll. The surface topography of 
collagen and heparin multilayers was observed by SEM analysis (Figure 2C). The presence of 
collagen molecules that had self-assembled into fibrils was found in the different samples. 
Specifically, highly fibrous meshes were observed on the surfaces coated with 10 hep/coll 
bilayers. Smoother surface topography and absence of aggregates were obtained with increasing 
hep/coll multilayers from 10 up to 20-bilayers. The macromolecular organisation of collagen into 
fibrillar structures and enhanced surface hydrophility is demonstrated with increasing numbers of 
hep/coll bilayers. Electrostatic interactions between heparin and atelocollagen have been 
reported to enhance parallel accretion during co-fibrillogenesis, since collagen microfibrils are 
stabilised by heparin action as cross-linker molecule inside the co-fibrils 10. The absence of the 
telopeptides on atelocollagen molecules (pepsin-digested soluble collagen) may favour the 
intercalation of highly negatively charged molecules such as heparin at a specific binding sites 10 
contributing to the limitations on the number of bilayers that can be assembled. 
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Results of static contact angle (hydrophilic properties), FTIR-ATR (chemical structure of 
films) and SEM (morphology of films) analysis demonstrated that the proper surface charge 
density is found between 10 and 15 bilayers of hep/coll, Ten bilayers of hep/coll were selected as 
the optimal number of hep/coll multilayers to be assembled onto polymeric substrates for cell 
studies. Figure 3A shows collagen and heparin concentrations present in 1 and 10-bilayers of 
hep/coll. Heparin and collagen concentration were determined by Taylor’s blue and Sirius red 
titration method, respectively. The heparin concentration present in just one layer of heparin was 
0.07 ± 0.03 µg/cm2 whilst in 10-layers was 0.91 ± 0.04 µg/cm2, nine times greater than in one 
layer of heparin. Moreover, the concentration held in one layer of collagen was 0.15 ± 0.02 
µg/cm2 while in 10 layers was 1.00 ± 0.02 µg/cm2. 
 
Figure 3. A. Bar diagrams of collagen and heparin concentration of substrates coated with 1 
(C1) and 10 films (C10)  of hep/coll by LbL technique. B. Bar diagrams of the biomolecules 
released at several time points. Data is presented as mean ± standard deviation of n=5 samples. 
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C. Survey XPS spectra of uncoated substrate and after coating by LbL assembly at 1 and 10 
films of hep/coll. 
XPS spectra confirmed the successful deposition of the multilayer coating showing the 
presence of nitrogen at 400 eV and sulphur at 169 eV that represent the characteristic elements of 
collagen and heparin (Figure 3C). Furthermore, as shown in Table 1, the content of nitrogen 
increased significantly from 1 to 10 heparin/collagen bilayers (from 4.3 % ± 2.3 % to 10.7 % ± 
0.2 %), evidencing the increase in the thickness of the resulted multilayer. The presence of 
sulphur was observed after 1 heparin/collagen bilayer, revealing the presence of the heparin 
coating. No increase was detected as the numbers of bilayers were increased, because the XPS 
spectra were obtained when the collagen was the top layer (nitrogen is the characteristic element 
of collagen whilst sulphur is the characteristic element from heparin). Furthermore, the insets, 
showing the high resolution spectrum of C1s from PLLA samples to C10, revealed the formation 
of the amide bond at (288.7 eV) from the collagen polyelectrolytes. 
Table 1. Atomic concentration of the characteristic element (N, C, O, S) detected on the 
substrate surface uncoated and coated with 1 and 10 films of hep/coll by LbL technique. Data is 
presented as mean ± standard deviation of n=3 samples. 
 C (At %) O (At %) N (At %) S (At %) 
PLLA 65.0 ± 0.4 34.7 ± 0.5 - - 
C1 73.9 ± 1.9 18.1 ± 0.8 4.3 ± 2.3 0.5 ± 0.2 
C10 71.3 ± 0.4  17.3 ± 0.4 10.7 ± 0.2 0.7 ± 0.1 
 
Effect of heparin-collagen multilayers on osteogenic cells line (MC3T3-E1). In vitro studies 
were assessed by MC3T3-E1 cell adhesion on PLLA substrates coated with 1 and 10 bilayers of 
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hep/coll and incubated for 24, 48 and 72 hours. Cell viability on substrates containing hep/coll 
films showed no significant differences compared to the control substrates, after 24 hours of 
incubation. However, a significant decrease in cell number was detected on substrates coated 
with hep/coll films compared to PLLA alone after 48 and 72 hours (Figure 4A). The presence of 
small amounts of heparin (H1) did not show significant differences (p < 0.05) in terms of cell 
adhesion compared to untreated polymeric substrates during 72 hours of cell culture. Increased 
cell adhesion has been related to decreased hydrophobicity 29, finding as optimal contact angle 
for cell adhesion about 60°. However, after 48 and 72 hours of incubation, lower cell adhesion 
was found on the more hydrophilic substrate C10 (~62°) in comparison to PLLA control (~80°). 
Cellular functions are triggered by the surface topography as well as by the chemistry and 
concentration of immobilised biomolecules on the substrate 30, therefore changes to surface 
physical-chemical properties (such as stiffness, topography, chemical composition, wettability, 
etc)  due to biomolecule organisation, release and layer dissociation has a direct impact on cell 
adhesion and morphology. In addition, the number of adherent cells decreases by adding a single 
collagen layer (C1) and with further increase of hep/coll multilayers (C10) after 48 and 72 hours 
of incubation.  Heparin is capable of interacting with several proteins involved in the bone 
formation process 31-32, including type I collagen, where the interaction involves a binding site in 
the telopeptide region 9, 33. A potential blocking of cell recognition sites of collagen by heparin 
intercalation 34 might also impact on cellular attachment 35.  
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Figure 4. A. MC3T3-E1 cell numbers on PLLA substrates coated with hep/coll films through 
LbL technique after 24 (blue), 48 (line pattern) or 72 hours (grid pattern). Data is presented as 
mean ± standard deviation of n=5 samples. (*) corresponds to a significant difference compared 
to PLLA control surface, for p<0.05. B. Fluorescence micrographs of cells attached on control 
substrates (PLLA), prepared heparin layer (H1), prepared hep/coll bilayer (C1) and 10-bilayers 
of hep/coll (C10) after 48 hours and C. 72 hours of incubation. Scale bars correspond to 50 µm. 
Cell adhesion provides mechanical linkage to a surface and influences not only cell shape but 
also proliferation, viability, motility and differentiation. Cell size and shape has also been shown 
to be inversely correlated with cell proliferation and migration 15, 36-37. Fluorescence microscopy 
analysis of cells attached to the different surfaces after 48 hours (Figure 4B) revealed that they 
were well spread, had extensive interactions and adopted a polygonal morphology on the 
different surfaces. The cells were also widely distributed over the entire surfaces showing no 
regional variations. Analysis of cell morphology after 48 and 72 hours on the different surfaces 
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revealed no significant differences in terms of cell area (Figure 4C), indicating that collagen and 
heparin multilayers may  not directly influence bone cellular phenotype through direct 
cytoskeletal organisation. The average cells area was measured for the various surfaces obtaining 
the following results: 1) the control group was 2264 ± 776 µm2, 2) heparin prepared layer was 
1236 ± 492 µm2, 3) hep/coll prepared bilayer was 1568 ± 852 µm2, and 4) 10-bilayers of hep/coll 
was 1228 ± 612 µm2. The differences of average cell area were not significant between hep/coll 
films and the control, using the ANOVA one-way test (p < 0.05).  
MC3T3-E1 activity on the different hep/coll coated surfaces may be influenced by the 
combination of two different effects: 1) molecular topography resulting from the concentration 
and organisation of heparin and collagen biomolecules on the polymeric substrate, and 2) the 
direct effect of localised heparin concentrations on cell function through control of growth factor 
availability/activity. The chemistry and topography of a surface can trigger specific cellular 
behaviour including cell spreading, migration, proliferation and differentiation, which eventually 
may affect the rate and quality of new tissue formation 38-39. The increase of hep/coll multilayers 
on the surface promoted a less fibrillary surface at the microscale as observed by SEM 
micrographs. Since bone cells are sensitive to slight differences in surface roughness and surface 
chemistry, the modifications in surface texture observed after biomolecule depositions may 
affect cell response. Cell numbers began to decrease over time on the surfaces containing 
increased numbers of hep/coll films. This effect may be caused by changes in surface 
morphology associated to the biomolecules desorption. 
Effect of heparin-collagen multilayers on hMSCs in vitro. Studies of cellular activity were 
carried out using human bone marrow-derived mesenchymal stem cells (hMSCs) to assess the 
effect of hep/coll multilayers on cellular fate. Substrates coated with hep/coll layers (heparin 
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alone, hep/coll bilayer and 10-films of hep/coll) and controls were incubated for 1, 3, 7, 14 and 
28 days. Figure 5A shows the hMSCs adhesion results on different substrates coated with 
hep/coll films in the short and long-term. In general, cell numbers did not show significant 
differences (p<0.05) between substrates coated with of hep/coll layers and control, except for 
surfaces with a heparin layer after 24 hour that showed increased cell number. Similarly, to 
MC3T3 results , hMSC numbers were reduced by introducing a layer of collagen (C1) and 
further increases of deposited hep/coll films (C10) in the short-term experiments. The lowest 
values for cell numbers were observed in surfaces coated with 10-bilayers of hep/coll at 7 days, 
in comparison to controls (PLLA) and the rest of substrates (H1 and C1). This effect was 
diminished in the long-term (14 and 28 days), since no significant differences were observed 
between the hep/coll films and control surfaces.  
  
Figure 5. A. Human MSCs viability. Cells were seeded at 20,000 cells/well and cultured for 1, 3 
and 7, 14 and 28 days days on control substrates (PLLA), and prepared with a heparin layer 
 24 
(H1), a hep/coll bilayer (C1) and 10 bilayers of hep/coll (C10). B. Alkaline phosphatase activity 
normalised to cell numbers adhered onto non-coated and hep/coll coated substrates after 7, 14 
and 28 days of incubation. Data is presented as mean ± standard deviation of n=3 samples. (*) 
corresponds to a significant difference compared to PLLA control surface, for p<0.05. C. ALP 
staining of differentiating hMSCs and calcium deposition on the different surfaces after i) 7 days 
and ii) 28 days of incubation. ALP-positive cells are shown in purple; mineral deposits pointed 
with black arrows were stained orange/red by Alizarin-Red. Scale bars correspond to 100 µm. 
Type I collagen, the main protein in the ECM, is known to stimulate the adhesion, proliferation 
and differentiation of hMSCs 40, whilst heparin influences cell adhesion and induces osteogenic 
differentiation of hMSC 41-42. Specific heparin-binding short peptide sequences have been also 
investigated to improve the osteoblastic mineralisation (FHRRIKA) 31 and adhesion (KRSR) 32. 
However, the effect induced by the combination of both biomolecules on hMSCs activity is 
poorly understood. Soluble collagen is prone to the intercalation of highly negatively charged 
molecules such as heparin in the specific binding site in the telopeptide region 10. Studies 
investigating collagen peptides have shown a greater heparin affinity in the C-terminal binding 
site than N-terminal binding site, only when the consensus sequence in surrounding residues are 
included 10, 33 . The specific collagen motif recognized by the α2-I domain is contained within the 
six-residue sequence GFOGER (O = hydroxyproline) 34. The blocking of the collagen cell-
binding domain by heparin intercalation at a specific binding site in the telopeptides region of 
collagen triple helix could prevent specific cell binding, decreasing the number of cells attached 
to the surface. 
Alkaline phosphatase activity (ALP) was evaluated to assess potential hMSCs differentiation 
on hep/coll films after 7, 14 and 28 days of incubation (figure 5B). In general, ALP activity 
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increased significantly on all substrates after 14 and 28 days. Surfaces containing 1 and 10 
bilayers hep/coll (C1 and C10) supported high levels of ALP activity as PLLA control at day 14 
and 28; whilst substrates containing a single layer of heparin (H1) showed significantly less ALP 
expression. Although, the result indicates that heparin has a direct impact on potential hMSC’s 
differentiation, the combination of collagen and heparin and further increases of multiple 
hep/coll layer may help osteogenic differentiation and stimulate osteoblast formation. 
ALP activity was stained purple/blue by Fast Blue RR whilst mineral deposits were coloured 
orange/red by Alizarin Red. Figure 5C shows the hMSCs cellular differentiation and mineral 
deposition after 14 days of incubation. After 7 days of incubation, hMSC’s showed negative 
stain of ALP activity and no mineral deposits were observed. However, after 28 days of culture, 
control PLLA and hep/coll coated substrates expressed ALP, evidenced purple staining. Mineral 
deposition was detected on samples coated with 10 bilayers of hep/coll (C10). Therefore, PLLA 
substrates coated with hep/coll multicoatings provide a more osteoinductive and osteoconductive 
environment for hMSC’s. 
Results presented in this work have evidenced that the presence of a single heparin layer may 
stimulate an initial cell adhesion of MC3T3 and hMSC’s, and prevent hMSC’s differentiation in 
the mid-long term. However, by combining electrostatically heparin with collagen molecules 
into multiple layers, for cell differentiation and mineral deposition is promoted. 
 
CONCLUSIONS 
Polyelectrolyte complex films made of collagen and heparin were successfully built–up on 
PLLA films using the LBL self-assembly method. PLLA substrates functionalised with isolated 
collagen type I and heparin presented a critical charge density close to 10-bilayers of hep/coll. 
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Heparin has been shown to play an important role on collagen molecules self-assembling into 
fibrils and in the stabilization of the fibrous collagen layer. Cell culture analysis using MC3T3-
E1 osteoblasts revealed that cell viability is reduced by increasing the number of deposited 
hep/coll films in the short-term. However, this work demonstrates that the presence of 
electrostatic hep/coll films do not inhibit hMSCs adhesion, self-renewal potential, lineage 
commitment, differentiation or mineralization but support contrasting and complex effects on 
short and long-term cells behaviour. The presence of multiple hep/coll bilayers electrostatically 
deposited on polymeric substrates reduces the initial cell adhesion whilst stimulating cellular 
differentiation and mineralisation at long term, providing a more osteoinductive and 
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